Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background: Rheumatoid arthritis (RA) is an autoimmune disease characterized by immune cell-mediated joint inflammation and subsequent osteoclast-dependent bone destruction. Collagen antibody-induced arthritis (CAIA) is a useful mouse model for examining the inflammatory mechanisms in human RA. Previously, we identified the novel gene Rab44, which is a member of the large Rab GTPase family and is highly expressed in immune-related cells and osteoclasts. Methods: In this study, we induced CAIA in Rab44-knockout (KO) mice to investigate the effects of Rab44 on inflammation, cell filtration, and bone destruction. Results: Compared with wild-type (WT) mice, Rab44-KO mice showed reduced inflammation in arthritis under CAIA-inducing conditions. Rab44-KO CAIA mice exhibited reduced cell filtration in the radiocarpal joints. Consistent with these findings, Rab44-KO CAIA mice showed decreased mRNA levels of arthritis-related marker genes including genes for inflammation, cartilage turnover, bone formation, and bone absorption markers. Rab44-KO CAIA mice exhibited predominant infiltration of M2-type macrophages at inflammatory sites and reduced bone loss compared to WT CAIA mice. Conclusions: These results indicate that Rab44 deficiency reduces the progression of inflammation in CAIA in mice.

Details

Title
Impaired Development of Collagen Antibody-Induced Arthritis in Rab44-Deficient Mice
Author
Yamaguchi, Yu 1 ; Kadowaki, Tomoko 2   VIAFID ORCID Logo  ; Sakai, Eiko 1 ; Noguromi, Mayuko 3 ; Oyakawa, Shun 4 ; Tsukuba, Takayuki 1   VIAFID ORCID Logo 

 Department of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan; [email protected] (Y.Y.); [email protected] (E.S.); [email protected] (M.N.); [email protected] (S.O.) 
 Department of Frontier Oral Science, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan; [email protected] 
 Department of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan; [email protected] (Y.Y.); [email protected] (E.S.); [email protected] (M.N.); [email protected] (S.O.); Department of Frontier Oral Science, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan; [email protected]; Department of Prosthetic Dentistry, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan 
 Department of Dental Pharmacology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan; [email protected] (Y.Y.); [email protected] (E.S.); [email protected] (M.N.); [email protected] (S.O.); Department of Prosthetic Dentistry, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8588, Japan 
First page
2504
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
22279059
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3132948325
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.